Search results
Nanobiotix Posts Updated Data For Radiotherapy-Activated Cancer Therapy In Head & Neck Cancer...
Benzinga via Yahoo Finance· 1 year agoNanobiotix (NASDAQ: NBTX) announced updated data from phase 1 Study 1100 of the NBTXR3 combo regime...
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
Benzinga via Yahoo Finance· 2 years agoNanobiotix (NASDAQ: NBTX) determined the recommended phase 2 dose (RP2D) of the NBTXR3 combo regime...
OncoSec Touts Encouraging Early Data For Opdivo Combined Immunotherapy For Skin Cancer
Benzinga via Yahoo Finance· 1 year agoOncoSec Medical Incorporated (NASDAQ: ONCS) announced early clinical data from an...